BC-CfE applauds France’s adoption of HIV treatment as prevention strategy

France has announced the adoption of the Treatment as Prevention (TasP) strategy, as pioneered by the BC Centre for Excellence in HIV/AIDS (BC-CfE), to combat HIV and AIDS.

France becomes the latest country to adopt TasP, originally endorsed by the Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2010. Since then, in 2011 China became the first nation to adopt the strategy, and the U.S. identified TasP as a key strategy to achieve an AIDS-free generation in 2012. More recently, in July 2013, the World Health Organization fully incorporated TasP in the new Global HIV Treatment Guidelines.

Read the full story

Leave a Reply

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below